🔎 Trials Near Me

Home › Glioblastoma › Ohio

Pag-aaral pangklinika para sa Glioblastoma sa Ohio

23 pag-aaral para sa Glioblastoma ang naghahanap ng mga kalahok sa mga site sa Ohio.

Mga Lungsod sa Ohio

Opisyal na teksto ng pag-aaral (English)

Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment

  • University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
  • Ohio State University Comprehensive Cancer Center, Columbus
  • University of Cincinnati Cancer Center-West Chester, West Chester
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT05432804

Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM

  • Neurological Institute Brain Tumor Centre Taussig Cancer Cente, Cleveland
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT05902169

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

  • Cleveland Clinic Taussig Cancer Center, Cleveland
  • Ohio State University, Columbus
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07326566

Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care

  • The Ohio State University, Columbus
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07195591

hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM)

  • University Hospitals Cleveland Medical Center, Cleveland
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 10, 2026 · NCT05052957

Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma

  • Case Western Reserve University, Cleveland
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 10, 2026 · NCT07452458

Targeted Pediatric High-Grade Glioma Therapy

  • Cincinnati Children's Hospital Medical Center, Cincinnati
  • Nationwide Children's Hospital, Columbus
Nagre-recruitObservasyonal na pag-aaral
12 Months – 39 Years · Lahat ng kasarian · Na-update Set 8, 2026 · NCT05839379

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

  • Ohio State University Comprehensive Cancer Center, Columbus
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT06860594

Study of Olutasidenib and Temozolomide in HGG

  • Cincinnati Children's Hospital Medical Center, Cincinnati
  • Nationwide Children's Hospital, Columbus
Nagre-recruitPhase 2
Edad 12 hanggang 39 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT06161974

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

  • Cleveland Clinic, Cleveland
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT05303519

A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas

  • Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute, Cleveland
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT07003542

Prospective Surgical Study on the Pattern of Electrical Activity in High Grade Glioma as a Predictor of Progression

  • Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT05565118

A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

  • University Hospitals Cleveland Medical Center*, Cleveland
  • Cleveland Clinic, Cleveland
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 30, 2026 · NCT03970447

Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma

  • Ohio State University Medical Center, Columbus
Nagre-recruit
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Hul 21, 2026 · NCT06910306

Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma

  • Ohio State University, Columbus
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Hul 17, 2026 · NCT07225621

DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)

  • The Ohio State University Comprehensive Cancer Center, Columbus
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 1, 2026 · NCT06805305

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

  • Cincinnati Children's Hospital Medical Center, Cincinnati
  • Nationwide Children's Hospital, Columbus
Nagre-recruitMaagang Phase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 1 hanggang 21 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT06333899

Study of an AAV Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma

  • Ohio State University Hospital, Columbus
Nagre-recruitPhase 1/2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Hun 12, 2026 · NCT07346144

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

  • Cincinnati Children's Hospital Medical Center, Cincinnati
  • Nationwide Children's Hospital, Columbus
Nagre-recruitPhase 2
12 Months – 39 Years · Lahat ng kasarian · Na-update May 29, 2026 · NCT05843253

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

  • Ohio State University Comprehensive Cancer Center, Columbus
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 13, 2026 · NCT06810544

Sacituzumab Govitecan in Recurrent Glioblastoma

  • Cleveland Clinic Taussig Cancer Center, Cleveland
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 30, 2026 · NCT04559230

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Cincinnati
  • Massive Bio SYNERGY-AI site, Columbus
  • Massive Bio SYNERGY-AI site, Mayfield Heights
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma

  • The Cleveland Clinic, Cleveland
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 25, 2025 · NCT05879367

Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.